CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL

被引：6
|
作者：
Pittner, BT
Jelinek, DF
Kay, NE
机构：
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
来源：
LEUKEMIA | 2004年 / 18卷 / 01期
关键词：
D O I：
10.1038/sj.leu.2403151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：180 / 182
页数：4
相关论文
共 50 条
  • [21] CD38 Expression Marks CLL - Cells with Invasive Properties
    Vaisitti, Tiziana
    Bologna, Cinzia
    Serra, Sara
    D'Arena, Giovanni
    Rossi, Davide
    Pepper, Chris
    Gaidano, Gianluca
    Malavasi, Fabio
    Deaglio, Silvia
    BLOOD, 2010, 116 (21) : 1004 - 1004
  • [22] CD38 bimodal expression profile identifies a distinct subset of CLL patients who will have a progressive disease.
    Ghia, P
    Guida, G
    Stella, S
    Scielzo, C
    Strola, G
    Geuna, M
    Gottardi, D
    Caligaris-Cappio, F
    BLOOD, 2002, 100 (11) : 592A - 592A
  • [23] Gene expression profiling suggests that B-CLL B cells from only a subset of B-CLL patients derive from CD5+CD19+ peripheral B-cells.
    Messmer, D
    Messmer, BT
    Allen, SL
    Kolitz, J
    Vinciguerra, V
    Rai, KR
    Chiorazzi, N
    BLOOD, 2001, 98 (11) : 149A - 149A
  • [24] Differential expression of CTLA-4 and HEM1 in B-CLL patients with high and low CD38 expression.
    Joshi, Avadhut Divakar
    Dickinson, John D.
    Armitage, James O.
    Bierman, Philip J.
    Bociek, Gregory R.
    Devetten, Marcel P.
    Vose, Julie M.
    Weisenburger, Dennis D.
    Joshi, Shantaram S.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S267 - S267
  • [25] Relative importance of CD38 expression over myeloid-associated markers expression in predicting the clinical course of B-CLL patients
    Chang, CC
    Liu, CZ
    Cleveland, RP
    LEUKEMIA & LYMPHOMA, 2003, 44 (06) : 977 - 982
  • [26] Differential expression of hem1 and CTLA-4 in B-CLL patients with high and low CD38 expression.
    Joshi, AD
    Dickinson, JD
    Lynch, JC
    Bierman, PJ
    Bociek, GR
    Devetten, MP
    Armitage, JO
    Joshi, SS
    BLOOD, 2005, 106 (11) : 595A - 595A
  • [27] CD38 expression in B-CLL is dynamic and changes due to contact with activating stimuli found within the leukaemic microenvironment.
    Patten, Piers E. M.
    Buggins, Andrea G. S.
    Richards, Julie
    Wotherspoon, Andrew
    Hamblin, Terry John
    Mufti, Ghulam
    Devereux, Stephen
    BLOOD, 2006, 108 (11) : 792A - 792A
  • [28] STUDY OF THE IMMUNOLOGICAL MARKERS CD49d AND CD38 IN EARLY-STAGE B-CLL PATIENTS
    Popova, Vanya
    Blazheva, Svetla
    Lukanov, Tsvetan
    Naneva, Silvia
    Tzvetkov, Nikolay
    JOURNAL OF IMAB, 2018, 24 (01): : 1883 - 1886
  • [29] CD38 as a prognostic factor in BCeH chronic lymphocytic leukaemia (B-CLL): Comparison of three approaches to analyze its expression
    Boonstra, JG
    van Lom, K
    Langerak, AW
    Graveland, WJ
    Valk, PJM
    Kraan, J
    van 't Veer, MB
    Gratama, JW
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2006, 70B (03) : 136 - 141
  • [30] CD38 expression in B-CLL is not fixed and may change due to contact with activating stimuli found within the leukaemic microenvironment
    Patten, PEM
    Buggins, AGS
    Richards, J
    Mufti, GJ
    Devereux, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 25 - 25
12345